Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency
    source: unsplash.com

    ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency

      The ENDO 2022 Annual Congress took place from June 11-14, 2022. During the Congress, stakeholders met to discuss care, treatments, and research within endocrinology. In a news release from…

    Continue Reading ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency
    IK-930 for NF2-deficient Malignant Pleural Mesothelioma Earns Fast Track Designation
    Source: https://unsplash.com/photos/ZHys6xN7sUE

    IK-930 for NF2-deficient Malignant Pleural Mesothelioma Earns Fast Track Designation

      For some patients with NF2-deficient malignant pleural mesothelioma (MPM), their cancer is unresectable, meaning that it cannot be surgically removed. Finding a way to better treat and assist these…

    Continue Reading IK-930 for NF2-deficient Malignant Pleural Mesothelioma Earns Fast Track Designation